RNActive-derived prostate cancer vaccine

N/A

Report date: 2026/05/13 09:17:24

Base Information

Drug NameRNActive-derived prostate cancer vaccine

Drug Alias NameRNActive源性前列腺癌疫苗CV-9104

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaSwedenPoland +[8]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCurevac Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCurevac Ag

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A